Qube Research & Technologies (QRT)
ODT

Qube Research & Technologies (QRT)’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-26,341
Closed -$354K – 2329
2020
Q3 		$354K Buy
+26,341
New +$746K 0.01% 1170

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ODT Position: Q4 2020 in Review

Qube Research & Technologies (QRT) sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q4 2020, closing a stake of 26,341 shares — an estimated $354K sold.

Qube Research & Technologies (QRT) first reported a position in ODT in Q3 2020 and held it in 1 quarter. The position peaked at $354K in Q3 2020. 94 funds tracked by Wall St. Rank hold ODT as of Q4 2020.

  • Qube Research & Technologies (QRT) reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 26,341 Odonate Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $354K.
  • Qube Research & Technologies (QRT) first reported a position in Odonate Therapeutics, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Odonate Therapeutics, Inc. Common Stock position peaked at $354K in Q3 2020.
  • 94 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2020, filed 16 Feb 2021.